A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations
Endeavor Biomedicines, Inc.
Endeavor Biomedicines, Inc.
GlaxoSmithKline
Iovance Biotherapeutics, Inc.
Labcorp Corporation of America Holdings, Inc
Cardinal Health 414, LLC
Bristol-Myers Squibb
Celgene